BeStock  
Stocks › Biotechnology › ABCL

AbCellera Biologics ABCL

US equityMarket cap rank #2395BiotechnologyAI medical concept stocks
$9.69 −$0.78 (-7.45%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $9.73 +0.41%
Open$10.14
Prev close$10.47
Day range$9.58 – $10.26
Volume4.25M
Market cap$3.16B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts9
Average target$19.33+99.5% vs. price
  • Buy 89%
  • Hold 11%
Low $14.00Now $9.69Avg $19.33High $30.00

Recent rating changes

The last 20 actions on file set price targets from $9.00 to $30.00, averaging $18.58.

DateFirmRatingTarget
12 Nov 2026 UBS BUY $18.00
10 Nov 2026 JonesTrading BUY $25.00
10 Nov 2026 Stifel BUY $14.00
10 Nov 2026 BMO Capital BUY $15.00
10 Nov 2026 J.P. Morgan BUY $17.00
9 Nov 2026 Cantor Fitzgerald BUY $20.00
9 Nov 2026 Goldman Sachs HOLD $14.00
30 Oct 2026 Jefferies BUY $21.00
12 Oct 2026 UBS BUY $18.00
29 Sep 2026 J.P. Morgan BUY $17.00
27 Sep 2026 JonesTrading BUY $25.00
24 Sep 2026 Goldman Sachs HOLD $13.00
2 Sep 2026 Truist Financial BUY $30.00
17 Aug 2026 BMO Capital BUY $15.00
11 Aug 2026 Truist Financial BUY $30.00
10 Aug 2026 JonesTrading BUY $25.00
10 Aug 2026 Truist Financial BUY –
10 Aug 2026 BMO Capital BUY $15.00
7 Aug 2026 Piper Sandler BUY $12.00
6 Aug 2026 Stifel BUY $9.00

Discussion

No comments yet — be the first to weigh in on ABCL.

Sign in to join the discussion.

Scroll to Top